Aducanumab may help treat Alzheimer’s Patients. This could be a big relief, as Alzheimer’s patients face challenges in the COVID-19 era of physical distancing, says Expert from American hospital, Cleveland Clinic.

‘COVID-19 era of physical distancing is seeing many Alzheimer’s patients separated or with reduced contact from their caregivers. New and innovative treatments that can reduce symptoms provides great relief.’
Read More..

Dr. Marwan Sabbagh, Director of Cleveland Clinic’s Lou Ruvo Center for Brain Health in Las Vegas, said: “While Alzheimer’s is widespread globally, it’s a very exciting time in the medical field with new and innovative treatments that can reduce symptoms.Read More..





Physicians, specialists, and medical researchers have a renewed sense of purpose in delivering innovations that can give back quality of life to patients, and deploy tests that can predict Alzheimer’s before it worsens.”
Alzheimer’s is the most common cause of the state of dementia, with Alzheimer’s impacting 60-80 percent of dementia cases, according to Cleveland Clinic. One in 10 people older than 65 and nearly half of all people older than 85 will have Alzheimer’s disease.
However, doctors and patients are welcoming breakthroughs in new blood tests, and an injectable radioactive agent for brain imaging, flortaucipir F18. In treatment, the US Food and Drug Administration is reviewing a new drug (aducanumab), which could reduce the amount of protein from the brain, and significantly slow the disease’s progression.
One of the biggest challenges facing patients with Alzheimer’s is the current COVID-19 era of physical distancing, especially for people in institutional living facilities.
Advertisement
“The COVID-19 era of physical distancing is seeing many Alzheimer’s patients separated or with reduced contact from their caregivers, leading to isolation and more challenging daily lives for these patients.”
Advertisement
Source-Medindia